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Abstract
Electrospinning is a very versatile techniqueused for many purposes, such as tissue
engineering,  textiles,  air  and  water  treatment  filter,  solar  cells,  and  drug  delivery
systems,  among others.  This  method is  cheap,  easy to  handle,  reproducible  when
ambient  parameters  are  controlled,  and  can  be  used  for  many  formulations.  The
objective of this review is to enlist and emphasize the advantages and disadvantages
of different methods for incorporating therapeutic drugs in a drug delivery system with
electrospinning. The importance of the research to create new and innovative drug
carriers is high, because of their efficiency of transporting the bioactive agent to the
target zone, avoiding secondary effects in the body. Nanofibers and nanoparticles have
become an important  strategy in  pharmacology due to  their  physicochemical  and
biocompatible properties useful for this purpose. Among the techniques compared are
blending  coaxial,  emulsion  and  surface  modification  electrospinning,  followed  by
electrospray  and  coaxial  electrospray.  The  present  review  concludes  that  every
technique has advantages and disadvantages and, not all drugs can be loaded with any
method, the strategy used will depend on the drug’s physicochemical properties, target
zone, polymeric characteristics, and required drug release rate. This chapter will serve
as  a  starting  point  for  when  to  choose  one  of  the  drug  incorporation  techniques
mentioned.
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1. Introduction
The electrospinning technique has been widely used for drug delivery system approach. This
versatile procedure uses an electrical field to create nanofibers from a conductive solution.
These solutions can be prepared from polymeric or composite materials [1–3].
Nanofibers fabricated by the electrospinning approach have been reported to be important in
the pharmaceutical industry thanks to its properties, such as degradability, high surface area,
variable porosity, and manageability; hence, these structures have been studied as drug
delivery systems. The polymers used in this technique usually facilitate the incorporation of
different drugs thanks to their chemical composition and physicochemical characteristics. For
example, poly(vinyl pyrrolidone) (PVP) scaffolds improve the solubility of some hydrophobic
drugs because PVP nanofibers help in the dispersion of these drugs [4].
Drug delivery systems that use the electrospinning strategy possess better control and
predictability on drug delivery than the conventional methods. Such is the case of itraconozale
used for the treatment of tinea pedis and other infections. This drug has been successfully
grafted in electrospun nanofibers showing a lineal dependence to a square root of release rate,
indicating that this drug delivery system follows a Fickian release kinetics [4].
In the case of mexofin, a cephalosporin antibiotic used to treat bacterial infections or preventing
bacterial infections before, during, or after certain surgeries, it has been reported to be loaded
to poly(D,L-lactid acid) (PDLLA) scaffolds showing a complete release of the drug within 24
h with a bulk release within the first 3 h. The researchers proposed that the surface deposition
and drug accumulation has an important effect on drug delivery performance of electrospun
nanofibers [5].
Other studies reported drug delivery systems using poly(ethylene-co-vinyl acetate) (PEVA)/
poly(lactic acid) (PLA) nanofibers loaded with the polyketide antibiotic tetracycline, well
known to treat periodontal diseases. Comparing the PEVA scaffolds with the PLA/PEVA
nanofibers, the first system proved to have a higher release, delivering 65% of the loaded drug
in 120 h [6].
Additionally, not only drugs can be loaded in electrospun nanofibers or microfibers, but also
biological agent can be controlled and released with this system. For this approach, it has been
reported that nanofibers with lower diameters are effective for delivering genes, proteins, and
enzymes in postsurgical treatment of glioma cells [4].
2. Advantages and disadvantages of nanofibers as drug carriers
Material uses for drug delivery systems need to be biocompatible, biodegradable, permit drug
loading, possess mass transfer properties, and respond to stimuli, among others. Drugs can be
loaded into the polymeric nanofibers from antibiotics and anticancer agents to biomolecules
such as DNA, RNA, and proteins [2].
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Among the advantages of electrospun nanofibers as drug carriers is the high surface-to-vol-
ume ratio, which can accelerate the solubility of the drug in the aqueous solution and im-
prove the efficiency of the drug. Surface morphology and structure of the nanofibers are
important factors for controlling the releasing rate and amount of the drug. Furthermore,
biodegradable polymers would protect drug from corrosion of gastric acid and enzyme,
maintaining the bioactivity of the drug. On the other hand, nanofibers scaffolds can be used
as templates for the production of conductive drug-loaded polymer systems [7].
It can be found in the literature that electrospinning is a cost-effective technique capable of
producing long and continuous nanofibers. Also, it is useful for the production of aligned
nanofiber and tailorable mechanical properties. Despite this, the method possesses several
limitations as production of large nanometer to micron-scale fiber requires the use of organic
solvents and it is not possible to control the 3D pore structure [8].
Compared with other methodologies, electrospinning is an easy and friendly technique.
One-step top-down process in the fabrication of nanoscale fibers is not limited in the copro-
cessing of polymeric mixtures or chemical cross-linking. The scaffolds made by electrospin-
ning possess various properties such as charged surfaces areas, adequate porosity, elasticity,
strength, and weight. The disadvantages of the other techniques for the production of nano-
fibers such as template synthesis, drawing, phase separation, and self-assembly are material
limitation, time consuming, and complex processing [9].
One of the important things to recognize about electrospinning is the demonstration of an
enhanced drug release rates using nanofiber formulation than those from original drug
substance reported in in vitro and in vivo studies [7].
3. Electrospun polymeric nanofibers as drug delivery systems
A great variety of polymers have been used to form nanofibers, such as poly(L-lactic acid)
(PLLA), poly(L-lactic acid)/hydroxyapatite (PLLA/HA) [10, 11], poly(glycolic acid) (PGA),
poly(caprolactone) (PCL), poly(carbonate), poly(urethane) (PU), poly(ethylene glycol)
(PEG) [1], poly(D,L-lactide-co-glycolide) (PLGA), PLGA/gelatin [7], poly(lactic acid)
(PLA), poly(ε-caprolactone) (PCL), poly(ethylene oxide), and poly(L-lactide-co-caprolac-
tone) [12], among others (Table 1).  But not all of them can be used for drug delivery
systems.
Many drugs have been loaded into nanofibers using different methods. Among these
drugs, chromazural B was successfully loaded into 5, 10, 15, 20-tetraphenyl-21H, 23H-
porphine tetrasulfonic acid tetrasodium (TPPS) fibers; in this work, the scientists con-
cluded that the fiber diameter was inversely proportional to the drug release rate [18]
(Table 2).
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Electrospun polymeric
nanofibers
Drug loaded Type of drug Ref.
Poly(vinyl alcohol) (PVA) Sodium salicylate,
diclofenac sodium,
naproxen (NAP), and
indomethacin (IND)
Freely soluble in water, sparingly soluble in water,
both insoluble in water, respectively
[13]
Poly(ethylene-co-vinyl acetate)
(PEVA)
Actisite® Antibiotic originally isolated from Streptomyces
aureofaciens
[14]
Poly(vinyl alcohol)/poly(vinyl
acetate)
Ciprofloxacin HCl
(CipHCl)
Antibiotic belong to a group of drugs called
fluoroquinolones
[15]
Poly(D,L-lactide-co-glycolide)
(PLGA), PLGA/gelatin
Fenbufen Nonsteroidal anti-inflammatory drug [7]
Poly(ɛ-caprolactone) (PCL) Naproxen (NAP) Non-steroidal anti-inflammatory drug (NSAID) of the
propionic acid class that relieves pain, fever, swelling,
and stiffness
[16]
Poly(vinyl alcohol) (PVA) and
sodium alginate (Na-Alg)
Insulin Pancreas´ hormone that allows the body to use sugar [17]
Table 1. Nanofibers as drug delivery systems.
Fibers/particles Drug loaded Observations Ref.
TPPS nanofibersa Chromazural B Smaller fibers exhibited rapid drug release in initial stage
No significant difference between the total amount of released
drug and the fiber diameter or type of drug, fiber diameter
between 150 and 290 nm
[18]
PNIPAAm
nanofibersb
Ketoprofen (KET) Exhibited fibers largely smooth and cylindrical, with no phase
separation
[3]
Gliadin nanoparticles Cyclophosphamide
anticancer drug
Particles are homogeneous and have a narrow distribution,
nanoparticles diameter between 218.66 ± 5.1 nm
[19]
PCLc and PHBVd
nanofibers
Metformin hydrochloride
(MH) or metoprolol tartrate
(MPT)
Emulsion electrospun nanofibers significantly alleviated the
burst release and produced a sustained release of drugs
compared to the blended electrospun nanofibers
[3]
aTPPS: 5,10,15,20-tetraphenyl-21H, 23H-porphine tetrasulfonic acid tetrasodium.
bPNIPAAm: poly(N-isopropyl acrylamide).
cPCL: poly(ε-caprolactone).
dPHBV: poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid).
Table 2. Characteristics of fibers and particles for drug delivery applications.
4. Drug incorporation techniques using electrospinning
Nanofibers are not the only product of electrospinning device useful for drug delivery
systems. It can also be applied to the electrohydrodynamic (EHD) technique, which allows
the production of nanoparticles of different shapes and sizes. This method employs several
techniques such as blending, coaxial process, and surface modulation, which permits the
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incorporation of any drug, DNA, and growth factors, depending on the treatment needed to
reach the proper material characteristics (Figure 1). Depending of the bioactive molecule
desirable to be loaded, the polymeric or composite system is carefully chosen, with the
purpose of the preservation of the therapeutic effect [12].
Figure 1. Drug incorporation techniques by electrospinning device. Adapted with permission from Ref. [11].
4.1. Blending electrospinning
The use of polymeric blend improves the equilibrium between mechanical and physicochem-
ical properties of the drug-loaded nanofibers. Also, it effectively increases the formulation
design for drug release, where the release rate can be manipulated by altering the proportion
of polymer in the blended solution [20].
When using the blending electrospinning method, drug encapsulation is achieved through
electrospinning in a single step, because drugs are dissolved or dispersed in the polymeric
solution (Figure 2). The interaction between polymer solution and drugs is affected by the
physicochemical properties of the polymers, because these characteristics act as factors that
determine the efficiency in drug encapsulation, drug dispersion into the fibers, and the release
rate. The isolated release of the drug into the solution can be triggered by the insufficient
solubility of the drug in the polymeric solution, where the drug molecules can migrate to a
nearby fiber’s surface during the electrospinning process. Researchers have emphasized the
importance of the equilibrium between hydrophilic and hydrophobic properties among drugs
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and polymers when blending electrospinning is used. For example, thanks to the hydrophobic
nature of some polymers, the lipophilicity of drugs becomes easier to get a homogeneous
solution, and vice versa. For example, polyester polymers, which are hydrophobic, interact
very well with the hydrophobic drug rifampicin and paclitaxel, and gelatin, PEG, and PVA,
which are hydrophilic polymers, can dissolve hydrophilic drugs such as doxorubicin [21].
With blending electrospinning fibers are obtained with a single phase only. If the objective is
to produce fibers with core-shell structure, which protect the labile biological agents and
growth factors, blending electrospinning is not the proper method. For this purpose, coaxial
and emulsion Electrospinning can be used [21].
Figure 2. Blending electrospinning principle.
Several reports can be found in the literature where blending electrospinning is used for the
loading of drug in a polymeric delivery system. A research, conducted by Lu et al., produced
fibers of poly (N-isopropyl acrylamide) (PNIPAAm), which is well known as a smart polymer
because it responds to pH and temperature stimuli, mixed with ethyl cellulose (EC), and it was
successfully blended by electrospinning, and ketoprofen (KET), a nonsteroidal anti-inflam-
matory drug, was added into the system. The resulting complexes exhibited fibers that are
largely smooth and cylindrical, with no phase separation. In this investigation, it was found
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that the drug was present in its amorphous physical form in the fiber matrix, and significant
intermolecular interaction between KET and the polymeric scaffold was observed. These
systems were not toxic and biocompatible in cell culture [3].
4.2. Coaxial electrospinning
The main purpose of coaxial electrospinning is to obtain fibers with core-shell structure. This
technique can be used to obtained fibers with specific drugs encapsulated in the core of the
fibers, which lead to a sustained and controlled drug release (Figure 3). These kinds of fibers
present a high surface area and three-dimensional network. Proteins, growth factor, antibiotics,
and other biological agents have been successfully loaded into the coaxial fibers for drug
delivery purposes. One of the main advantages of this technique is that the core-shell structure
gives protection to the loaded compound and the bioactivities of drugs, for example, remain
intact [9].
Figure 3. Coaxial electrospinning principle.
Among the coaxial electrospinning method benefits is the enhancing of biomolecule function-
ality, by having it into the inner jet, while the electrospinning process is working and the
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polymeric solution is in the outer jet giving protection to the biomolecule. In this technique,
the polymeric shell helps to avoid the direct contact of the biomolecule with the external
environment. The core-shell system improves the sustained release of drugs and also allows
the bioability of unstable biological agents to be maintained [21].
4.3. Emulsion electrospinning
Emulsion electrospinning is a flexible and potential technique for the encapsulation of several
drugs into nanofibers [3] and is one of the most important methods for preparing core-shell
electrospun nanofibers in a cost-effective and efficient manner (Figure 4) [9].
Figure 4. Emulsion electrospinning principle.
Using emulsion electrospinning fibers composed of poly (ε-caprolactone) (PCL) and poly (3-
hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV) were loaded with metformin hydro-
chloride (MH) or metoprolol tartrate (MPT). In this study, emulsion electrospinning
demonstrated to be a better technique than blending electrospinning, especially in the
modulation of the drug release rate by regulating the oil phase and water phase of the
emulsions for obtaining the desired drug release. Between the two polymers tested, PCL
showed better drug delivery properties than PHBV [3].
In the emulsion electrospinning method, the oil phase is created by the emulsion of the drug
or aqueous protein solution in the polymer solution, followed by electrospinning. When the
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drug to be load has a sufficient low molecular weight, the biomolecule-loaded phase can be
distributed within the fiber or a core-shell fibrous structure could be configured as macromo-
lecules amalgamate in the aqueous phase. The advantage of emulsion electrospinning against
blending electrospinning is the elimination of the need for a common solvent as the drug and
the polymer are dissolved in applicable solvents. Subsequently, a number of formulations of
hydrophilic drugs and hydrophobic polymeric solution can be used while maintaining
minimal drug contact with the organic solvent during the procedure [21].
4.4. Surface modification electrospinning
In this strategy, thanks to the electrospinning approach, a particular conductive surface can be
chemically altered and changed, with the purpose of modifying the external properties of the
coated device, by incorporating certain molecules that can camouflage the surface by offering
a similar environment than the tissue that will surround the implanted material. Usually this
strategy is applied to avoid fast initial burst release and slow the rate of immobilization of the
biological molecules on a particular surface. In addition, with a good electrospinning system
and with a well-standardized method to create electric field inside a camera, it is possible to
coat 3D surfaces with nanoparticles or homogeneous surfaces (Figure 5) [21].
Figure 5. Surface modification electrospinning principle.
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4.5. Electrospray
Electrospray is one of the most effective methods for the synthesis of nanoparticles and
nanospheres. This technique is the simplest of all the drug incorporation methods. In this
process, the liquid emerging from the nozzle into the electrical field forms the Taylor cone
because of the surface tension. Once the electric field increases, the Taylor cone breaks into
highly charged droplets, creating suitable conditions for the formation of nanoparticles or
microparticles. Solid particles are formed by solvent evaporation (Figure 6). Some of the
parameters that need to be taken into account are the needle gauge diameter, flow rate, voltage,
and distance from the needle to the conductive collector, promoting the right incorporation of
the drug [19].
Figure 6. Electrospray principle.
Electrosprayed nanoparticles can be useful for biological, medicinal, and pharmaceutical
applications; hence, it is zero dimensional in nature. The advantages of electrospraying include
increased scalable synthesis, reproducibility, and high encapsulation efficiency [19].
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In addition, with this technique nanoparticles can be loaded with pharmaceutical molecules
like drugs and biomolecules acting as particular transporters due to its active surface absorp-
tion, binding capacity, and complexation with drugs and bioactive molecules. Moreover, the
particles of a nanoscale size are important in therapeutic treatments, because they improve the
drug carrier rate, specificity, adhesion, and reactivity [19].
For this strategy, the use of nanoparticles of natural gliadin loaded with cyclophosphamide
anticancer drug has been reported for the treatment of retinoblastoma and certain cancers. In
this study, over 72% of drug loading was accomplished; researchers reported homogeneous
nanoparticles with average diameters of 218 ± 5.1 nm [19].
4.6. Coaxial electrospray
Coaxial electrospray allows the production of multilayer particles with sizes ranging between
10 and 100 µm by using a high electric field between coaxial capillary needle and ground. In
this technique, the resultant electrical shear stress elongates the core and the shell liquid
menisci at the needle outlet to form the “Taylor cone”; after this phenomenon, the jet of the
liquid elongates enough until it is broken into multilayer droplets owing to the electrohydro-
dynamic forces (Figure 7) [22].
Figure 7. Coaxial electrospray principle.
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This method achieves high encapsulation rate, precise control of the core-shell structure, and
protection of the fragile therapeutic cargos from process-induced denaturation and aggrega-
tion. Also, this process is scalable for mass production of drug-loaded microparticles and
nanoparticles [22].
Moreover, coaxial electrospray leads to a microencapsulation and a nanoencapsulation of
drugs into polymeric particles. To perform this method it is necessary to use a coaxial capillary
needle to deliver two liquids independently. Several liquid materials can be used including
glycerol, distilled or deionized water, ethanol, ethylene glycol, etc. For the synthesis of
multilayer macroparticles and nanoparticles with a hard shell, polymeric solution, such as
PCL, PLA, PLGA, PMMA, PE, among others, can be used [22].
In general, all methods for drug incorporation using electrospinning possess its advantages
and limitations (Table 3).
Method Advantages Disadvantages Ref.
Blending
electrospinning
Improves the tunability of the physicochemical and
mechanical properties of the drug-loaded fibers.
Benefits the development of controlled drug release
formulations, for which the release rate can be
modified by altering the ratio of the polymers in the
blend
A clear understanding of the phase
behavior of the processed polymer
blend is essential
[20,
21]
Coaxial
electrospinning
Enhanced biomolecule functionality. The core
ingredient is shielded by the shell polymer avoiding
direct contact to the biological environment
Need a special syringe tip [21]
Emulsion
electrospinning
No need of a common solvent as the drug and the
polymer are dissolved in applicable solvents
Not all drugs can be loaded by this
method
[21]
Surface
modification
electrospinning
Resolve the issues of large initial burst release and
short release time as the biomolecules are surface
immobilized
Depend of the nature of polymers and
drugs
[21]
Electrospray Easy to control the operation parameters. Fast
preparation and one-step technique. This involves
simple ideology. This technique can be able to
extend for bulk production
This technique may induce some
macromolecule degradation due to the
stress involved in the operation
parameters (ex: thermal stress in
drying, shear stress in the nozzle)
[19]
Coaxial
electrospray
High encapsulation efficiency, effective protection
of bioactivity and uniform size distribution
Process control in coaxial electrospray
is challenged by the multiphysical
nature of the process and the complex
interplay of multiple design, process
and material parameters
[22]
Table 3. Advantages and disadvantages of drug incorporation methods using electrospinning.
Electrospinning - Material, Techniques, and Biomedical Applications152
5. Conclusion
This chapter summarized reported drug incorporation techniques developed from electrospun
nanofibers and nanoparticles, from polymers used to a comparison between the techniques.
Coaxial electrospray and coaxial electrospinning can be used when a core-shell structure is
need, for example, in cases when the therapeutic agent is sensible to the environment. Blending
and emulsion electrospinning do not need special equipment and are the simplest methods to
incorporate drugs into nanofibers. Finally, surface modification is necessary when the rampage
effect needs to be avoided and more perdurable release rate is desired. All techniques are
useful, versatile, cheap, and easy for the incorporation of drug in a drug delivery system. The
method must be chosen depending on the nature of the therapeutic agents.
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